Latest Post | Page 528 of 1332 | IASbaba

SPEAK TO MENTOR - CALL NOW!

SUBSCRIBE

2-deoxy-D-glucose approved by DGCI

Part of: GS Prelims and GS – II – Health; GS- III – Sci & tech

In news

Drugs Controller General of India (DCGI) approved anti-COVID drug 2-deoxy-D-glucose for emergency use.
Developed by: Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad.

Key takeaways

Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
The drug will be of immense benefit to the people suffering from COVID-19.
The drug comes in powder form in sachet, which is taken orally by dissolving it in water.
It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production.
Its selective accumulation in virally infected cells makes this drug unique.

Your Name *

Your Email *

Subject

Comments *

Search now.....